Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $87.6 million.

  • GeneDx Holdings' Total Current Liabilities rose 13.29% to $87.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 13.29%. This contributed to the annual value of $54.8 million for FY2024, which is 6.80% down from last year.
  • As of Q3 2025, GeneDx Holdings' Total Current Liabilities stood at $87.6 million, which was up 22.71% from $71.4 million recorded in Q2 2025.
  • GeneDx Holdings' Total Current Liabilities' 5-year high stood at $204.6 million during Q2 2022, with a 5-year trough of $50.7 million in Q1 2024.
  • Moreover, its 3-year median value for Total Current Liabilities was $69.5 million (2025), whereas its average is $73.7 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 161,372.03% in 2021, then crashed by 59.24% in 2023.
  • GeneDx Holdings' Total Current Liabilities (Quarterly) stood at $101.3 million in 2021, then surged by 42.47% to $144.3 million in 2022, then crashed by 59.24% to $58.8 million in 2023, then dropped by 6.80% to $54.8 million in 2024, then climbed by 13.29% to $87.6 million in 2025.
  • Its last three reported values are $87.6 million in Q3 2025, $71.4 million for Q2 2025, and $69.5 million during Q1 2025.